Literature DB >> 12033949

Alpha-helix structure in Alzheimer's disease aggregates of tau-protein.

Mourad Sadqi1, Felix Hernández, UnMei Pan, Mar Pérez, Michael D Schaeberle, Jesús Avila, Victor Muñoz.   

Abstract

The discovery of beta-sheet structure in Alzheimer's amyloid fibrils, and then in many other disease-related protein fibrils, has led to the widely believed view that beta-sheet formation is the general mechanism of aberrant protein aggregation leading to disease. This notion is further reinforced by recent findings, which indicate that normal proteins can be induced to form beta-sheet fibrils in vitro. Alzheimer's disease, a paradigm proteopathy, is accompanied by the formation of two distinct aggregates, amyloid fibrils and paired helical filaments (PHFs). Electron microscope images of PHFs show pairs of twisted ribbons with 80 nm periodicity. However, there is little information of the molecular structure of PHFs, as previous studies have failed to identify signs of regular structure. Using far-UV circular dichroism and Fourier-transformed infrared spectroscopy, we find that PHFs are comprised of alpha-helices. This is remarkable as tau-protein, PHF's primary constituent, has a high abundance of helix-breaking amino acids and is unstructured in solution. We also find that PHFs are very stable, as judged by their high melting temperature and resistance to protease digestion. PHFs are the first example of pathological aggregation associated to the formation of alpha-helix.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12033949     DOI: 10.1021/bi025777e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

Review 1.  From Alzheimer to Huntington: why is a structural understanding so difficult?

Authors:  Piero Andrea Temussi; Laura Masino; Annalisa Pastore
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

Review 2.  Molecular interactions of amyloid nanofibrils with biological aggregation modifiers: implications for cytotoxicity mechanisms and biomaterial design.

Authors:  Durga Dharmadana; Nicholas P Reynolds; Charlotte E Conn; Céline Valéry
Journal:  Interface Focus       Date:  2017-06-16       Impact factor: 3.906

3.  Identification of a key functional region in harpins from Xanthomonas that suppresses protein aggregation and mediates harpin expression in E. coli.

Authors:  Xiaoyu Wang; Ming Li; Jiahuan Zhang; Yan Zhang; Guiying Zhang; Jinsheng Wang
Journal:  Mol Biol Rep       Date:  2006-12-19       Impact factor: 2.316

4.  A proposed signaling motif for nuclear import in mRNA processing via the formation of arginine claw.

Authors:  Donald Hamelberg; Tongye Shen; J Andrew McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-06       Impact factor: 11.205

Review 5.  Tau aggregation in Alzheimer's disease: what role for phosphorylation?

Authors:  Guy Lippens; Alain Sillen; Isabelle Landrieu; Laziza Amniai; Nathalie Sibille; Pascale Barbier; Arnaud Leroy; Xavier Hanoulle; Jean-Michel Wieruszeski
Journal:  Prion       Date:  2007-01-23       Impact factor: 3.931

6.  Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus.

Authors:  Ghulam M Ashraf; Nigel H Greig; Taqi A Khan; Iftekhar Hassan; Shams Tabrez; Shazi Shakil; Ishfaq A Sheikh; Syed K Zaidi; Mohammad Akram; Nasimudeen R Jabir; Chelaprom K Firoz; Aabgeena Naeem; Ibrahim M Alhazza; Ghazi A Damanhouri; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

Review 7.  Amyloidogenesis of Tau protein.

Authors:  Bartosz Nizynski; Wojciech Dzwolak; Krzysztof Nieznanski
Journal:  Protein Sci       Date:  2017-09-13       Impact factor: 6.725

Review 8.  Intrinsically disordered proteins in the neurodegenerative processes: formation of tau protein paired helical filaments and their analysis.

Authors:  Rostislav Skrabana; Jozef Sevcik; Michal Novak
Journal:  Cell Mol Neurobiol       Date:  2006-06-16       Impact factor: 5.046

9.  Structure of core domain of fibril-forming PHF/Tau fragments.

Authors:  Hideyo Inouye; Deepak Sharma; Warren J Goux; Daniel A Kirschner
Journal:  Biophys J       Date:  2005-12-09       Impact factor: 4.033

10.  Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure.

Authors:  John Berriman; Louise C Serpell; Keith A Oberg; Anthony L Fink; Michel Goedert; R Anthony Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.